Lv11
80 积分 2020-12-19 加入
Cancer drug approvals and setbacks in 2024
12小时前
已完结
混合型高脂血症基层诊疗中国专家共识（2024年）
1个月前
已完结
A new perspective on therapies involving B-cell depletion in autoimmune diseases
1个月前
已完结
VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study
1个月前
已完结
Novel and future lipid-modulating therapies for the prevention of cardiovascular disease
1个月前
已完结
Targeting the peripheral neural-tumour microenvironment for cancer therapy
3个月前
已完结
Targeting cytokine networks in neuroinflammatory diseases
3个月前
已完结
Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study
3个月前
已完结
Broadening horizons with 225Ac-DOTATATE targeted alpha therapy for gastroenteropancreatic neuroendocrine tumour patients stable or refractory to 177Lu-DOTATATE PRRT: first clinical experience on the efficacy and safety
3个月前
已完结
New epilepsy therapies in development
5个月前
已完结
皖公网安备34019202002308
